当前位置:首页 - 行情中心 - 凯普生物(300639) - 财务分析 - 资产负债表

凯普生物

(300639)

  

流通市值:36.65亿  总市值:37.30亿
流通股本:6.35亿   总股本:6.47亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金905,902,260.49709,501,229.43640,241,504.6764,931,888.81
应收票据及应收账款1,375,456,417.281,746,789,347.071,834,168,779.671,890,591,087.21
其中:应收票据3,553,079.413,289,529.973,256,746.622,485,256.01
应收账款1,371,903,337.871,743,499,817.11,830,912,033.051,888,105,831.2
预付款项12,207,779.2110,148,942.7612,867,068.3611,359,591.92
其他应收款合计16,613,124.7716,504,003.9620,167,593.5813,560,430.66
其中:应收利息6,884,412.04---
存货87,759,672.42100,957,041.5196,838,096.1499,557,906.71
其他流动资产96,567,213.5896,626,348.8892,937,968.6989,869,717.88
流动资产平衡项目0000
流动资产合计2,494,553,729.992,840,582,138.512,977,276,749.663,176,925,297.43
非流动资产:
长期股权投资30,118,553.0329,968,056.2232,646,291.9130,427,412.38
其他权益工具投资300,647,509.55300,655,749.89300,670,149.58288,697,319.54
其他非流动金融资产214,000,000214,000,000214,000,000214,000,000
固定资产1,199,207,763.771,238,394,579.821,210,681,791.081,240,848,457.88
在建工程194,237,568.07195,117,087.18176,867,665.15171,377,982.4
使用权资产16,853,859.5620,624,012.2622,861,222.1125,131,585.12
无形资产262,354,817.27257,949,092.31247,374,279.21249,583,717.5
开发支出21,457,417.4822,641,018.3731,093,012.5927,217,386.11
长期待摊费用39,365,483.1444,059,954.3655,982,823.4852,735,097.3
递延所得税资产263,890,029.93204,914,275.19199,742,958.36195,346,003.92
其他非流动资产56,943,130.7954,103,280.259,267,225.6753,500,758.74
非流动资产平衡项目0000
非流动资产合计2,599,076,132.592,582,427,105.82,551,187,419.142,548,865,720.89
资产平衡项目0000
资产总计5,093,629,862.585,423,009,244.315,528,464,168.85,725,791,018.32
流动负债:
短期借款21,402,910.55500,388.89500,473.612,118,599.99
应付票据及应付账款95,164,481.88126,147,404.16113,939,032.24143,665,795.99
应付账款95,164,481.88126,147,404.16113,939,032.24143,665,795.99
预收款项---0
合同负债13,841,442.869,863,910.68,283,129.258,934,450.01
应付职工薪酬57,274,761.8861,756,597.3266,920,097.0282,211,720.12
应交税费20,933,709.4716,896,125.154,161,620.0682,897,097.8
其他应付款合计164,772,103.68164,052,538.81165,562,850.29178,553,738.87
应付股利9,520,414.319,618,613.73-9,560,361.36
一年内到期的非流动负债6,866,943.277,957,057.347,093,465.928,863,202.29
其他流动负债668,372.42777,666.87619,889.58671,163.9
流动负债平衡项目0000
流动负债合计380,924,726.01387,951,689.14367,080,557.97507,915,768.97
非流动负债:
长期借款52,783,217.5652,777,481.3928,268,475.3528,268,475.35
租赁负债13,021,582.4216,323,689.3317,672,263.8817,402,299.85
预计负债46,895.6246,895.6246,895.6246,895.62
递延收益9,700,575.2810,403,527.2711,111,559.8511,819,592.41
递延所得税负债54,957,782.4758,674,224.2460,082,784.8161,601,702.57
其他非流动负债0--0
非流动负债平衡项目0000
非流动负债合计130,510,053.35138,225,817.85117,181,979.51119,138,965.8
负债平衡项目0000
负债合计511,434,779.36526,177,506.99484,262,537.48627,054,734.77
所有者权益(或股东权益):
实收资本(或股本)646,500,674646,500,674646,500,674649,149,874
资本公积777,688,624.89777,658,238.17782,696,275.7877,518,246.44
减:库存股60,125,682.4433,129,110.9130,108,299.09100,000,734.93
其他综合收益180,691,322.41196,975,182.52188,095,529.53187,256,870.09
专项储备0--0
盈余公积87,555,295.287,555,295.287,555,295.287,555,295.2
一般风险准备0--0
未分配利润2,856,140,551.333,041,134,437.433,145,442,520.863,159,797,302.79
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,488,450,785.394,716,694,716.414,820,181,996.24,861,276,853.59
少数股东权益93,744,297.83180,137,020.91224,019,635.12237,459,429.96
股东权益平衡项目0000
股东权益合计4,582,195,083.224,896,831,737.325,044,201,631.325,098,736,283.55
负债和股东权益合计5,093,629,862.585,423,009,244.315,528,464,168.85,725,791,018.32
公告日期2024-10-302024-08-292024-04-272024-04-24
审计意见(境内)标准无保留意见
TOP↑